Decomposition of Small Molecules for Fragment-Based Drug Design

2Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

In the drug design process, a frequent task is the decomposition of small molecules into fragments. There exist a number of approaches and methods to break molecules into fragments. However, a method that allows the decomposition of molecules into non-overlapping fragments that is meaningful in terms of medicinal chemistry is absent, and in this work, we present a new simple approach for the decomposition of molecules—MedChemFrag. It aims to break drug-like molecules into a set of rings and linkers, which are close to the perception of “fragments” by medicinal chemists. In contrast to most previous efforts aimed at breaking molecules using retrosynthetic feasible rules, our approach strives to preserve the functional groups, which may reveal the specific interaction pattern, e.g., the amide groups.

Cite

CITATION STYLE

APA

Ivanov, N. N., Shulga, D. A., & Palyulin, V. A. (2023). Decomposition of Small Molecules for Fragment-Based Drug Design. Biophysica, 3(2), 362–372. https://doi.org/10.3390/biophysica3020024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free